Full IDE Data Set Demonstrates Sustained Benefit at One Year with Use of AMDS in Acute DeBakey Type I (ADTI) Dissections Complicated by Malperfusion ATLANTA, Jan. 27, 2025 /PRNewswire/ --...

Triumvira Immunologics, a clinical-stage company developing novel, targeted autologous and allogeneic T cell therapeutics that co-opt the natural biology of T cells to treat patients with solid...

Amidst the AI-driven landscape of passed CES 2025, smart home ecosystems are redefining consumer expectations. As a pioneering brand in the electronics industry, Toshiba TV continues to push the...

IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation in the upcoming...

Vantage Markets made a significant impact at the highly anticipated iFX Expo Dubai 2025, held on 15-16 January at the Dubai World Trade Centre. As an Elite Sponsor, Vantage showcased its...